[Galenic innovation: Enantone monthly depot preparations].
Hübner
R
R
D000970:Antineoplastic Agents; D003692:Delayed-Action Preparations; D004334:Drug Administration Schedule; D006801:Humans; D007279:Injections, Subcutaneous; D016729:Leuprolide / Q000008:administration & dosage* / Q000493:pharmacokinetics; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000097:blood / Q000628:therapy*; D011471:Prostatic Neoplasms / Q000097:blood / Q000628:therapy*
D000970:Antineoplastic Agents; D003692:Delayed-Action Preparations; D016729:Leuprolide
Die galenische Innovation: Enantone Monats-Depot.